Entering text into the input field will update the search result below

Affymetrix (NASDAQ:AFFX) says Q3 revenue will be about $80M, short of consensus $85M, due to...

Oct. 08, 2012 7:19 AM ETAffymetrix, Inc. (AFFX) StockAFFXBy: Jason Aycock, SA News Editor
Affymetrix (NASDAQ:AFFX) says Q3 revenue will be about $80M, short of consensus $85M, due to concerns about tighter academic funding globally and euro weakness. Some $18M will come from its eBioscience business, without which revenues will be "flat to slightly down" for the year. Results are due after the close Oct. 31.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
AFFX--
Affymetrix, Inc.